These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2485136)

  • 1. Selective accumulation of a new antineoplastic agent, K-18 (human immunoglobulin conjugated melphalan), in Ehrlich carcinoma transplanted in mice.
    Nio Y; Imai S; Ohgaki K; Tobe T
    In Vivo; 1988; 2(3-4):177-87. PubMed ID: 2485136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and internalization of human immunoglobulin G conjugated with melphalan (K18) to human tumor cell lines.
    Nio Y; Shiraishi T; Imai S; Ohgaki K; Tobe T
    Anticancer Res; 1989; 9(1):59-63. PubMed ID: 2468306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new anti-cancer agent K-18 (conjugate of human IgG and melphalan). (I). K-18 accumulates selectively into the tumor].
    Nio Y; Tsuchitani T; Imai S; Ohgaki K; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2257-73. PubMed ID: 3819552
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo antineoplastic activity of mouse or human IgG conjugated with melphalan.
    Sugita N; Niimura K; Fujii M; Matsunaga K; Fujii T; Furusho T; Yoshikumi C; Kawai Y; Taguchi T
    In Vivo; 1987; 1(4):205-13. PubMed ID: 2979787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of the antineoplastic activity of K18].
    Nakatani K; Miyagi N; Ezaki T; Sugisaki T; Sakamoto K; Watanabe A; Fujioka T; Shiratori T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1985-91. PubMed ID: 2423038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of K-18 and concomitant hyperthermia for treatment of Lewis lung carcinoma in mice.
    Tamada R; Kai H; Sugimachi K; Takenaka K; Hiramoto Y; Inokuchi K
    Jpn J Surg; 1985 Mar; 15(2):173-6. PubMed ID: 2409315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo inhibitory effect of a conjugate of immunoglobulin G and melphalan, K18, on human tumors transplanted in nude mice.
    Imai S; Nio Y; Shiraishi T; Tsubono M; Morimoto H; Ohgaki K; Tobe T
    Anticancer Res; 1989; 9(2):453-9. PubMed ID: 2787617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of orally administered streptococcal preparation, OK-432 on murine solid tumors and its absorption from the gut.
    Nio Y; Shiraishi T; Tsuchitani T; Tobe T; Sugawara Y; Saito M; Kamiyama H
    In Vivo; 1989; 3(5):307-13. PubMed ID: 2519870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory effect of a conjugate of human immunoglobulin G and melphalan, K18, on DNA synthesis of human tumor cells.
    Shiraishi T; Nio Y; Imai S; Ohgaki K; Tobe T
    Anticancer Res; 1989; 9(3):599-604. PubMed ID: 2475050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of K18 on metastatic models.
    Fujii T; Furusho T; Niimura K; Sugita N; Oguchi Y; Matsunaga K; Saito K; Kobayashi Y; Iijima H; Fujii M
    In Vivo; 1988; 2(6):389-92. PubMed ID: 2485138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of 14C-nicotinic acid in mice with Ehrlich ascites tumor].
    Mikhal'tsevich GN; Trebukhina RV
    Vopr Pitan; 1981; (5):30-4. PubMed ID: 7314612
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of the antitumour effect of K18.
    Fujii T; Niimura K; Furusho T; Sugita N; Oikawa M; Takahashi N; Yoshimura M; Oguchi Y; Iijima H; Matsunaga K
    J Int Med Res; 1989; 17(2):132-40. PubMed ID: 2721813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of antibody-forming capacities by PS-K in tumor-bearing mice.
    Nomoto K; Yoshikumi C; Matsunaga K; Fujii T; Takeya K
    Gan; 1975 Aug; 66(4):365-74. PubMed ID: 1183773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [99mTc-ethylenediamine-N, N-diacetic acid; a radiopharmaceutical with tumor affinity].
    Imoto T
    Fukuoka Igaku Zasshi; 1984 May; 75(5):221-40. PubMed ID: 6436155
    [No Abstract]   [Full Text] [Related]  

  • 16. [14C-riboflavin metabolism in mice with Ehrlich's ascitic tumor].
    Trebukhina RV; Mikhal'tsevich GN
    Vopr Pitan; 1978; (4):49-55. PubMed ID: 685222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenine metabolism of Ehrlich mouse ascites cells in proliferating and resting phase of tumor growth.
    Grune T; Siems W; Uhlig R; Jakstadt M
    Biochem Int; 1992 Feb; 26(2):199-209. PubMed ID: 1558533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation of radiolabeled D-methionine as a parent compound in potential nuclear imaging.
    Takeda A; Goto R; Tamemasa O; Chaney JE; Digenis GA
    Radioisotopes; 1984 Apr; 33(4):213-7. PubMed ID: 6473836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of iron on 67Ga distribution in tumor-bearing mice--effect of iron administered after 67Ga injection (author's transl)].
    Higashi T; Shimura A; Wakao H
    Radioisotopes; 1981 Jul; 30(7):385-90. PubMed ID: 7323324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine formation and metabolism during adenosine triphosphate catabolism in Ehrlich ascites tumor cells.
    Lomax CA; Henderson JF
    Cancer Res; 1973 Nov; 33(11):2825-9. PubMed ID: 4748438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.